# Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache

> **NCT07714369** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 40 (estimated)

## Conditions studied

- Cluster Headache

## Interventions

- **DRUG:** Zavegepant 20 mg

## Key facts

- **NCT ID:** NCT07714369
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07714369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07714369, "Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07714369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*